Jefferies reduced its rating on Molina Healthcare MOH from Hold to Underperform and lowered its price target from $20 to $19.
Jefferies noted, "MOH's valuation places a heavy bet on take-out, we think. Even if that does happen, the valuation would have to meaningfully exceed AGP's takeout multiple to make it interesting from here. CA Duals seem to present a low probability for operational upside in 2013. 2014 should see positive margin, but that's a long time and a lot of execution risk to hold through. We are downgrading MOH to Underperform from Hold and lowering our price target another dollar to $19 from $20.
Molina Healthcare closed at $23.14 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in